A) SOURCES: Hydrogen cyanide is a gas that may be liquified as hydrocyanic acid. It may be produced during petroleum refining, electroplating, metallurgy and photographic-developing operations. Occupational exposure to hydrogen cyanide may occur during the manufacture of resin monomers (eg, acrylates and methyl methacrylate), cyanide salts (such as sodium and potassium cyanides) and nitrile compounds (eg, acrylonitrile, adiponitrile).
B) USES: Hydrogen cyanide is used in the production of chemical intermediates in synthetic fiber, plastics, nitriles, dyes, chelates, rodenticides, pesticides, hexamethylenediamine and the manufacturing of cyanide salts, and is used to fumigate ships, railroad cars, buildings, orchards, tobacco and certain foods.
C) TOXICOLOGY: Hydrogen cyanide is a highly toxic substance. Systemic poisoning can occur following inhalation, dermal, and oral exposure. Hydrogen cyanide exposure may produce death within minutes. Cyanide is a general cellular poison resulting in impaired oxygen utilization and lactic acidosis. It interferes with oxidative phosphorylation by inhibiting cytochrome oxidase which prevents aerobic production of energy.
D) EPIDEMIOLOGY: Rare exposure that can result in significant morbidity and mortality.
E) WITH POISONING/EXPOSURE
1) MILD TO MODERATE TOXICITY: Nausea, vomiting, headache, weakness, confusion, dizziness and shortness of breath.
2) SEVERE TOXICITY: Coma, transient loss of consciousness with apnea ("knockdown"), hypotension, metabolic acidosis, seizures, and dysrhythmias.
0.2.20 REPRODUCTIVE HAZARDS
A) At the time of this review, no reproductive studies were found for hydrogen cyanide in humans.
B) In laboratory animals, related cyanide compounds did cause resorptions, malformations and teratogenic effects in offspring.
0.2.21 CARCINOGENICITY
0.2.21.1 IARC CATEGORY
A) IARC Carcinogenicity Ratings for CAS74-90-8 (International Agency for Research on Cancer (IARC), 2016; International Agency for Research on Cancer, 2015; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2010; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2010a; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2008; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2007; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2006; IARC, 2004):
1) Not Listed
0.2.21.2 HUMAN OVERVIEW
A) At the time of this review, no studies were found on the potential carcinogenic activity of hydrogen cyanide in humans.
0.2.21.3 ANIMAL OVERVIEW
A) At the time of this review, no studies were found on the potential carcinogenic activity of hydrogen cyanide in laboratory animals.
0.2.22 GENOTOXICITY
A) At the time of this review, no data were available to assess the mutagenic or genotoxic potential of this agent.
The information contained in the Truven Health Analytics Inc. products is intended as an educational aid only. All treatments or procedures are intended to serve as an information resource for physicians or other competent healthcare professionals performing the consultation or evaluation of patients and must be interpreted in view of all attendant circumstances, indications and contraindications. The use of the Truven Health Analytics Inc. products is at your sole risk. These products are provided "as is" and "as available" for use, without warranties of any kind, either express or implied. Truven Health Analytics Inc. makes no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the productsAdditionally, Truven Health ANALYTICS INC. makes no representation or warranties as to the opinions or other service or data you may access, download or use as a result of use of the Truven Health ANALYTICS INC. products. All implied warranties of merchantability and fitness for a particular purpose or use are hereby excluded. Truven Health Analytics Inc. does not assume any responsibility or risk for your use of the Truven Health Analytics Inc. products.